ITGB2 and Alzheimer disease: One target, integrin subunit beta 2 (Itgb2) has been identified as a member of the module identified by Zhang et al. (2013) to be most highly associated with AD onset in human patients, suggesting that target in particular harbors translational relevance to human disease.